The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets
Author:
Affiliation:
1. International Centre for Circulatory Health, National Heart and Lung Institute; Imperial College London; London UK
Funder
MJS-S
DPF
GDC
British Heart Foundation
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Reference24 articles.
1. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions;Crespo-Leiro;Eur J Heart Fail,2016
2. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey;Komajda;Eur J Heart Fail,2016
3. ‘Can I come off the tablets now?’ A qualitative analysis of heart failure patients' understanding of their medication;Field;Fam Pract,2006
4. ‘Triple therapy’ of heart failure with ACE inhibitor, beta-blocker and aldosterone antagonist may triple survival time: shouldn't we tell patients?;Cole;JACC Heart Fail,2014
5. Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using placebo control: recommendations for patient information;Barron;Int J Cardiol,2013
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in detection, prevention and treatment of heart failure in type 2 diabetes: part II;British Journal of Diabetes;2024-06-29
2. Digital model for predicting the risk of developing acute decompensated heart failure;Rational Pharmacotherapy in Cardiology;2024-06-18
3. 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction;Journal of the American College of Cardiology;2024-04
4. The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients;JACC: Heart Failure;2024-04
5. Latest pharmaceutical approaches across the spectrum of heart failure;Heart Failure Reviews;2024-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3